VENLO, Netherlands, Nov. 3 /PRNewswire-FirstCall/ -- QIAGEN N.V. today announced the Webcast of its third quarter 2008 financial results call. The Webcast will take place at 9:30 a.m. EST on Tuesday, November 11, and will include remarks by Peer M. Schatz, President and Chief Executive Officer, and Roland Sackers, Chief Financial Officer.
QIAGEN N.V., a Netherlands holding company, is the leading provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 consumable products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN’s assay technologies include what is considered to be the broadest panel of molecular diagnostic tests available worldwide. This panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer.
QIAGEN employs more than 2,900 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com.
(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from http://www.real.com/products/player/index.html, or The Windows Media Player, downloadable free from www.microsoft.com and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an email to webmaster@vdat.com.)
CONTACT: Andreas Marathovouniotis of Russo Partners, +1-212-845-4235, for
QIAGEN
Web site: http://www.qiagen.com/
http://www.qiagen.com/goto/ConferenceCall/
